Physician profile
Andra Matthews
NPI 1053901058
$1,319.61
in general payments reported to CMS, 2019-2025
16 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $453 · 2022: $532 · 2023: $77.12 · 2024: $123 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $497.90 | 2021-2025 | |
| Janssen Biotech, INC. | $157.34 | 2021-2025 | Rybrevant, Carvykti |
| Astellas Pharma US INC | $131.87 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $94.23 | 2021-2024 | Keytruda, Welireg |
| Astrazeneca Pharmaceuticals LP | $88.35 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $77.60 | 2022 | |
| Taiho Oncology, INC. | $43.50 | 2022-2023 | |
| Rochester Medical Corporation | $42.81 | 2021 | |
| Janssen Scientific Affairs, LLC | $38.56 | 2024 | Akeega, Balversa, Rybrevant |
| Eisai INC. | $33.30 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $29.07 | 2021 | |
| Seagen INC. | $18.83 | 2021 | |
| Puma Biotechnology, INC. | $17.61 | 2023 | |
| Kci USA, INC. | $16.69 | 2023 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Gilead Sciences, INC. | $16.24 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andra Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.